GO
Loading...

Pfizer Inc

More

  • Tuesday Look Ahead: Melting the Glacier Monday, 20 Oct 2008 | 8:25 PM ET

    Investors Tuesday will again be watching for progress in the credit markets, where the trickle from a slow thaw has been enough to end the drought of buyers in the stock market.

  • Your First Move For Tuesday October 21st Monday, 20 Oct 2008 | 7:10 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Dow Up More Than 400 Points Monday, 20 Oct 2008 | 6:01 PM ET

    The Dow made another triple digit move on Monday this time soaring more than 400 points higher.

  • Dow Rallies 400 Points After Late Surge Monday, 20 Oct 2008 | 4:54 PM ET

    Stocks rallied to the finish line after another volatile session as signs began to emerge that credit markets may be defrosting.  The Dow gained more than 400 points.

  • Stocks Chug Higher After Paulson Remarks Monday, 20 Oct 2008 | 3:15 PM ET

    Stocks were higher in a wobbly session as investors digested remarks from Federal Reserve Chairman Ben Bernanke and Treasury Secretary Hank Paulson.

  • Web Extra: Antidote For Market Volatility Friday, 17 Oct 2008 | 7:18 PM ET

    Despite a slowing economy, drug stocks such as Abbott Labs and Genentech posted positive earnings reports. Is health care the best defensive play in this market?

  • Fast & Furious Trades For The Week Ahead Friday, 17 Oct 2008 | 7:09 PM ET

    Following are the “Fast & Furious” trades - hot ways to play next week's market moving events.

  • Game Plan: Merck Is Right for This Market Friday, 17 Oct 2008 | 7:04 PM ET

    A drug stock with a safe dividend? That's just what you need in this tough environment.

  • Giving the Grade to Five Popular Stocks Friday, 17 Oct 2008 | 2:39 PM ET

    Some stocks are more popular than others. But that doesn't mean they're always the best shares to hold. Michael Farr, president of Farr, Miller and Washington, gave his assessment of five of the most widely held companies.

  • Lilly In The "Pink"--But Then Again Not Friday, 17 Oct 2008 | 10:57 AM ET
    Effient Ad

    I don't think Eli Lilly will be running any more "Coming Soon" ads--like the one posted here for its late-stage experimental bloodthinner Effient--for drugs that haven't been approved yet by the Food and Drug Administration.

  • The Last Word--For Now--On Dendreon Wednesday, 8 Oct 2008 | 10:55 AM ET

    Since there should really be no compelling reason to blog or report on Dendreon and Provenge for quite awhile, here's one last hurrah.

  • Where Are The Buying Opportunities? Tuesday, 7 Oct 2008 | 6:59 PM ET

    Which stocks have been unfairly punished over the last three trading days?

  • Fear Factor Vs. Opportunity Knocking Tuesday, 7 Oct 2008 | 4:01 PM ET

    Wall Street struggled with another day of selling as panic seemed to accelerate into the final minutes of trading.

  • Could The Credit Crisis Help Pfizer? Monday, 6 Oct 2008 | 3:46 PM ET

    Pretty much all of biopharma is caught in the downdraft of the markets today with the notable exception of Dendreon (data) and ImClone Systems (a deal).

  • Dendreon, ImClone & Pfizer: Your Emails Friday, 3 Oct 2008 | 10:37 AM ET

    As all eyes remain on Capitol Hill, things remain relatively quiet on the biopharma front. So, it's a good time to go through the Pharma's Market mailbag. The overwhelming majority of emails recently have been about...yeah, you guessed it...Dendreon.

  • Mad Mail: What Happened to China? Thursday, 2 Oct 2008 | 10:17 PM ET

    Plus, should I own Pfizer?

  • Stocks Fall On Bailout Uncertainty Wednesday, 1 Oct 2008 | 5:41 PM ET

    The Dow closed lower on Wednesday as nervous investors found it difficult to muster enthusiasm ahead of the Senate’s vote on a revamped $700 billion rescue plan.

  • The Waiting Game Continues For Lilly & ImClone Monday, 29 Sep 2008 | 10:42 AM ET

    Eli Lilly has been running direct-to-doctor ads over the past few months telling physicians that Effient, the company's new bloodthinner, is "Coming Soon". Well, it may have jumped the gun.

  • Lilly

    Today is the day the FDA is expected to make a decision on the drug. The agency could approve it outright, approve it with conditions/limitations, delay making a decision--again--and order more tests, or reject the pill.

  • S&P Slammed Monday, 22 Sep 2008 | 5:56 PM ET

    The Dow tumbled on Monday as investors worried a $700 billion bailout for the financial sector may not resuscitate a slumping economy...